Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The problem with platinum.

Literature DB >> 26605762

The problem with platinum.

David Holmes.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2015 PMID： 26605762 DOI： 10.1038/527S218a

Source DB: PubMed Journal: Nature ISSN： 0028-0836 Impact factor: 49.962

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer.

Authors: Kelly M Kreitzburg; Samuel C Fehling; Charles N Landen; Tracy L Gamblin; Rebecca B Vance; Rebecca C Arend; Ashwini A Katre; Patsy G Oliver; Robert C A M van Waardenburg; Ronald D Alvarez; Karina J Yoon
Journal: Cancer Lett Date: 2018-08-16 Impact factor: 8.679

2. Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer.

Authors: Shini Liu; Qiong Zou; Jie-Ping Chen; Xiaosai Yao; Peiyong Guan; Weiting Liang; Peng Deng; Xiaowei Lai; Jiaxin Yin; Jinghong Chen; Rui Chen; Zhaoliang Yu; Rong Xiao; Yichen Sun; Jing Han Hong; Hui Liu; Huaiwu Lu; Jianfeng Chen; Jin-Xin Bei; Joanna Koh; Jason Yongsheng Chan; Baohua Wang; Tiebang Kang; Qiang Yu; Bin-Tean Teh; Jihong Liu; Ying Xiong; Jing Tan
Journal: J Clin Invest Date: 2021-10-15 Impact factor: 14.808

3. Long noncoding RNA lncBRM facilitates the proliferation, migration and invasion of ovarian cancer cells via upregulation of Sox4.

Authors: Jie Xi; Jing Feng; Saitian Zeng
Journal: Am J Cancer Res Date: 2017-11-01 Impact factor: 6.166

4. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.

Authors: Xiaolan Zhu; Huiling Shen; Xinming Yin; Lulu Long; Xiaofang Chen; Fan Feng; Yueqin Liu; Peiqing Zhao; Yue Xu; Mei Li; Wenlin Xu; Yuefeng Li
Journal: Oncotarget Date: 2017-06-13

5. Mitochondria-targeted spin-labelled luminescent iridium anticancer complexes.

Authors: V Venkatesh; Raul Berrocal-Martin; Christopher J Wedge; Isolda Romero-Canelón; Carlos Sanchez-Cano; Ji-Inn Song; James P C Coverdale; Pingyu Zhang; Guy J Clarkson; Abraha Habtemariam; Steven W Magennis; Robert J Deeth; Peter J Sadler
Journal: Chem Sci Date: 2017-10-20 Impact factor: 9.825

The problem with platinum.

1. FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer.

2. Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer.

3. Long noncoding RNA lncBRM facilitates the proliferation, migration and invasion of ovarian cancer cells via upregulation of Sox4.

4. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.

5. Mitochondria-targeted spin-labelled luminescent iridium anticancer complexes.

6. LINC01118 Modulates Paclitaxel Resistance of Epithelial Ovarian Cancer by Regulating miR-134/ABCC1.

7. Identification and Characterization of a New Platinum-Induced TP53 Mutation in MDAH Ovarian Cancer Cells.

8. Systemic Analysis of the DNA Replication Regulator MCM Complex in Ovarian Cancer and Its Prognostic Value.

9. Enzyme-Regulated Supramolecular Assemblies of Cholesterol Conjugates against Drug-Resistant Ovarian Cancer Cells.

10. Long noncoding RNA NBAT-1 suppresses tumorigenesis and predicts favorable prognosis in ovarian cancer.